IRVINE, Calif.--(BUSINESS WIRE)--eGene Inc. (OTCBB:EGEI), a leading biotechnology company and developer of a compact and automated digital genetic analyzer, announced today that the Company has received notice of allowance from the US Patent Office of its decision to grant a patent for the "MULTI-SEGMENT CARTRIDGE FOR BIO-SEPARATION WITH MULTIPLEXED FLUORESCENCE DETECTION." This marks the Company's 7th US patent and 10th patent worldwide.
